Oklo, a pre-revenue nuclear fission specialist, has surged 97% over the past year amid AI-driven energy demand. While the company could eventually pay substantial dividends if its nuclear technology reaches commercial viability, the path remains highly speculative. With $1.2 billion in cash but significant losses and no revenue, investors should understand the long-term uncertainty before betting on future dividend income.

Oklo, a nuclear start-up developing small modular reactors (SMRs), is positioned as a potential long-term retirement stock. Unlike typical nuclear companies that sell reactors, Oklo plans to build and operate its Aurora Powerhouse facilities, selling generated electricity like a utility. The company is pre-commercial with operations not expected until late 2027, making it a high-risk, speculative investment suitable only for investors with 10+ years until retirement.

Small modular reactor (SMR) stocks NuScale Power and Oklo have experienced significant volatility in 2026 after surging in 2024-2025. While SMR technology remains promising long-term, investors should be nervous about execution risks, including delayed project timelines, capital requirements, and uncertainty around converting contracts into real revenues. Both companies face the need for significant capital raises that will dilute shareholders.

While Oklo's liquid-metal-cooled small modular reactor (SMR) technology is innovative and addresses AI's growing power demands, the company generates no revenue and is losing money rapidly. BWX Technologies is presented as a better SMR investment alternative, as it has established revenue, profitability, and diversified business operations beyond SMR development.

NuScale Power, a small modular nuclear reactor (SMR) startup, is positioned as a solid long-term buy ahead of its Q4 earnings report. The company has secured regulatory approval for two SMR designs from the U.S. Nuclear Regulatory Commission and recently signed a $6-7 billion contract with Romanian nuclear provider Nuclearelectrica. Despite being unprofitable since its 2022 public debut and a 33% decline over the past 12 months, NuScale benefits from growing government support for nuclear energy and its small market cap that allows for significant upside on positive catalysts.

NuScale Power stock has plummeted 77% from its October 2025 all-time high of $57.42 to around $13, driven by AI bubble concerns, missed Q3 earnings estimates, share dilution, and major shareholder Fluor's exit. However, the company's first project approval in Romania with Nuclearelectrica offers a potential turnaround, though commercial operation isn't expected until 2033. The stock remains highly speculative for volatile-tolerant investors.

Centrus Energy, America's only NRC-licensed HALEU producer, is positioned to benefit from surging nuclear power demand driven by AI data centers and government initiatives to triple nuclear energy production. The company has a $2.3 billion backlog, strong cash position ($1.95 billion), and is investing heavily in expansion. Despite an 83% surge over the past 12 months, the author believes the stock's growth is justified by solid fundamentals rather than hype.

As AI electricity demand surges, small modular reactor (SMR) companies Oklo and NuScale are positioned to benefit. While Oklo has more innovative liquid-metal reactor technology, it generates no revenue until 2027-2028. NuScale has secured a major TVA contract for 6 gigawatts of SMR capacity and generated $8.2 million in Q3 2025 revenue, making it the stronger choice for risk-averse speculative investors despite its smaller market cap.

NuScale Power stock declined 5.99% after Barclays reduced its price target by 67% from $45 to $15, maintaining an equal weight rating. Goldman Sachs also recently trimmed its price target to $20 from $23. Investors should await the company's Q4 2025 earnings report on Thursday for updates on commercial operations progress.

Oklo and NuScale Power are competing in the small modular reactor (SMR) market. While NuScale has regulatory approval and first-mover advantage, Oklo's smaller reactor design offers more flexibility and diversification through its Atomic Alchemy acquisition. The author favors Oklo for long-term growth potential despite both stocks being high-risk, high-reward investments.

Oklo, a pre-revenue advanced fission reactor company, surged 238% in 2025 and currently trades at $63.81 with an $11B market cap. The company has binding agreements with major partners like Meta and Siemens Energy, with first reactor deployments expected in 2027. While awaiting NRC licensing approval, Oklo presents high-risk, high-reward potential for patient investors with strong risk tolerance.

NuScale Power, a nuclear technology company with the only U.S. NRC-approved small modular reactor design, faces challenges despite significant long-term potential. While data center power demand could surge 175% by 2030, NuScale has no firm sales yet and is burning cash with losses. Trading at 68x sales with a $4.1B market cap, the stock presents high risk and volatility despite transformative technology potential.